Pantethine rescues phosphopantothenoylcysteine synthetase and phosphopantothenoylcysteine decarboxylase deficiency in Escherichia coli but not in Pseudomonas aeruginosa

Journal of Bacteriology

Volumn 193, Issue 13, 2011, Pages 3304-3312

  Balibar, Carl J ^a   Hollis Symynkywicz, Micah F ^a   Tao, Jianshi ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COENZYME A; PANTETHINE; PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE; PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; GENETIC CODE; GENETIC COMPLEMENTATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BIOSYNTHETIC PATHWAYS; CARBOXY-LYASES; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE DELETION; GENES, ESSENTIAL; GENETIC COMPLEMENTATION TEST; MULTIENZYME COMPLEXES; PANTETHEINE; PEPTIDE SYNTHASES; PSEUDOMONAS AERUGINOSA;

ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

EID: 79959342177     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00334-11     Document Type: Article

References (51)

1. Abiko, Y. 1967. Investigations on pantothenic acid and its related compounds. IX. Biochemical studies. 4. Separation and substrate specificity of pantothenate kinase and phosphopantothenoylcysteine synthetase. J. Biochem. 61:290-299.
2. Abiko, Y. 1967. Investigations on pantothenic acid and its related compounds. X. Biochemical studies. 5. Purification and substrate specificity of phosphopantothenoylcysteine decarboxylase from rat liver. J. Biochem. 61: 300-308.
3. Abiko, Y., M. Tomikawa, and M. Shimizu. 1968. Further studies on phosphopantothenoylcysteine synthetase. J. Biochem. 64:115-117.
4. Anderson, M. S., C. E. Bulawa, and C. R. Raetz. 1985. The biosynthesis of gram-negative endotoxin. Formation of lipid A precursors from UDPGlcNAc in extracts of Escherichia coli. J. Biol. Chem. 260:15536-15541.
5. Angus, B. L., A. M. Carey, D. A. Caron, A. M. Kropinski, and R. E. Hancock. 1982. Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob. Agents Chemother. 21:299-309.
6. Baba, T., et al. 2006. Construction of Escherichia coli K-12 in-frame, singlegene knockout mutants: the Keio collection. Mol. Syst. Biol. 2:1-11.
7. Balibar, C. J., X. Shen, and J. Tao. 2009. The mevalonate pathway of Staphylococcus aureus. J. Bacteriol. 191:851-861.
8. Begley, T. P., C. Kinsland, and E. Strauss. 2001. The biosynthesis of coenzyme A in bacteria. Vitam. Horm. 61:157-171.
9. Beveridge, T. J. 1981. Ultrastructure, chemistry, and function of the bacterial wall. Int. Rev. Cytol. 72:229-317.
10. Brand, L. A., and E. Strauss. 2005. Characterization of a new pantothenate kinase isoform from Helicobacter pylori. J. Biol. Chem. 280:20185-20188.
11. Choudhry, A. E., et al. 2003. Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections. Antimicrob. Agents Chemother. 47: 2051-2055.
12. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
13. Daugherty, M., et al. 2002. Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics. J. Biol. Chem. 277:21431-21439.
14. Espinosa-Ruiz, A., J. M. Belles, R. Serrano, and F. A. Culianez-MacIa. 1999. Arabidopsis thaliana AtHAL3: a flavoprotein related to salt and osmotic tolerance and plant growth. Plant J. 20:529-539.
15. Gerdes, S. Y., et al. 2002. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J. Bacteriol. 184:4555-4572.
16. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
17. Guzman, L. M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121-4130.
18. Hancock, R. E., and H. Nikaido. 1978. Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J. Bacteriol. 136: 381-390.
19. Harrington, C. R., and J. Baddiley. 1985. Biosynthesis of wall teichoic acids in Staphylococcus aureus H, Micrococcus varians and Bacillus subtilis W23. Involvement of lipid intermediates containing the disaccharide N-acetylmannosaminyl N-acetylglucosamine. Eur. J. Biochem. 153:639-645.
20. Heath, R. J., S. W. White, and C. O. Rock. 2001. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40:467-497.
21. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
22. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
23. Jackowski, S. 1996. Biosynthesis of pantothenic acid and coenzyme A, p. 687-694. In F. C. Neidhardt, R. Curtiss, C. A. Gross, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology, vol. 1. American Society for Microbiology, Washington, DC.
24. Jackowski, S., and J. H. Alix. 1990. Cloning, sequence, and expression of the pantothenate permease (panF) gene of Escherichia coli. J. Bacteriol. 172: 3842-3848.
25. Jackowski, S., and C. O. Rock. 1984. Metabolism of 4'-phosphopantetheine in Escherichia coli. J. Bacteriol. 158:115-120.
26. Kotnik, M., P. S. Anderluh, and A. Prezelj. 2007. Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis. Curr. Pharm. Des. 13:2283-2309.
27. Kropinski, A. M., J. Kuzio, B. L. Angus, and R. E. Hancock. 1982. Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 21:310-319.
28. Kupke, T., P. Hernandez-Acosta, and F. A. Culianez-Macia. 2003. 4'-Phosphopantetheine and coenzyme A biosynthesis in plants. J. Biol. Chem. 278: 38229-38237.
29. Leonardi, R., et al. 2005. A pantothenate kinase from Staphylococcus aureus refractory to feedback regulation by coenzyme A. J. Biol. Chem. 280:3314-3322.
30. Leonardi, R., Y. M. Zhang, C. O. Rock, and S. Jackowski. 2005. Coenzyme A: back in action. Prog. Lipid Res. 44:125-153.
31. Levintow, L., and G. Novelli. 1954. The synthesis of coenzyme A from pantetheine: preparation and properties of pantetheine kinase. J. Biol. Chem. 207:761-765.
32. Meier, J. L., A. C. Mercer, H. J. Rivera, and M. D. Burkart. 2006. Synthesis and evaluation of bioorthogonal pantetheine analogues for in vivo protein modification. J. Am. Chem. Soc. 128:12174-12184.
33. Mendelson, M. H., et al. 1994. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin. Infect. Dis. 18:886-895.
34. Mercer, A. C., J. L. Meier, J. W. Torpey, and M. D. Burkart. 2009. In vivo modification of native carrier protein domains. Chembiochem 10:1091-1100.
35. Poole, K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.
36. Poole, K. 2004. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10:12-26.
37. Rana, A., et al. 2010. Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 107:6988-6993.
38. Rubio, S., et al. 2006. An Arabidopsis mutant impaired in coenzyme A biosynthesis is sugar dependent for seedling establishment. Plant Physiol. 140:830-843.
39. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. Schweizer, H. D. 1993. Small broad-host-range gentamycin resistance gene cassettes for site-specific insertion and deletion mutagenesis. Biotechniques 15:831-834.
41. Simon, R., U. Priefer, and A. Puehler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gramnegative bacteria. Nat. Biotechnol. 1:784-791.
42. Strauss, E., and T. P. Begley. 2002. The antibiotic activity of N-pentylpantothenamide results from its conversion to ethyldethia-coenzyme A, a coenzyme A antimetabolite. J. Biol. Chem. 277:48205-48209.
43. Strauss, E., C. Kinsland, Y. Ge, F. W. McLafferty, and T. P. Begley. 2001. Phosphopantothenoylcysteine synthetase from Escherichia coli. Identification and characterization of the last unidentified coenzyme A biosynthetic enzyme in bacteria. J. Biol. Chem. 276:13513-13516.
44. Thomas, J., and J. E. Cronan. 2010. Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme A synthesis. Antimicrob. Agents Chemother. 54:1374-1377.
45. Vallari, D. S., and C. O. Rock. 1985. Isolation and characterization of Escherichia coli pantothenate permease (panF) mutants. J. Bacteriol. 164: 136-142.
46. Vallari, D. S., and C. O. Rock. 1987. Isolation and characterization of temperature-sensitive pantothenate kinase (coaA) mutants of Escherichia coli. J. Bacteriol. 169:5795-5800.
47. Vallari, D. S., and C. O. Rock. 1985. Pantothenate transport in Escherichia coli. J. Bacteriol. 162:1156-1161.
48. Wu, Z., C. Li, S. Lv, and B. Zhou. 2009. Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model. Hum. Mol. Genet. 18:3659-3672.
49. Zhang, Y. M., et al. 2004. Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites. J. Biol. Chem. 279:50969-50975.
50. Zhou, B., et al. 2001. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28:345-349.
51. Zimmermann, W. 1979. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics. Int. J. Clin. Pharmacol. Biopharm. 17:131-134.